Jefferies analyst Glynis Johnson maintained a Hold rating on Holcim on April 3 and set a price target of CHF72.60. Johnson covers the Consumer Cycl......

Jefferies analyst Edison Lee maintained a Buy rating on China Mobile on April 3 and set a price target of HK$97.46. According to TipRanks, Lee is a......

The latest announcement is out from Healthier Choices Management ( ($HCMC) ). On March 27, 2026, Healthier Choices Management Corp. entered into a ......

First Shanghai Securities analyst maintained a Buy rating on China Mobile yesterday and set a price target of HK$108.00. Currently, the analyst con......

In a report released yesterday, Glynis Johnson from Jefferies maintained a Hold rating on Holcim, with a price target of CHF73.20. The company’s sh......

In a report released yesterday, from Bank of China maintained a Buy rating on China Mobile, with a price target of HK$98.54. The company’s shares c......

HUTCHMED (China) ( ($HK:0013) ) has shared an update. HUTCHMED has begun a registrational Phase III clinical trial in China of its investigational ......

In a report released on March 20, Prieto Luis from Kepler Capital maintained a Buy rating on Holcim, with a price target of CHF90.00. The company’s......

In a report released today, Julian Radlinger from UBS maintained a Buy rating on Holcim, with a price target of CHF93.00. Radlinger covers the Basi......

In a report released on March 13, from SPDB maintained a Buy rating on HUTCHMED (China) , with a price target of HK$28.00. The company’s shares clo......